Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference26 articles.
1. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis;Adya;Cardiovasc. Res.,2008
2. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments;Aimes;J. Biol. Chem.,1995
3. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells;Bernhard;Proc. Natl. Acad. Sci. USA,1994
4. Matrix metalloproteinases: a review;Birkedal-Hansen;Crit. Rev. Oral Biol. Med.,1993
5. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways;Carnevale;Mol. Endocrinol.,2007
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Paracrine effects of the senescence-associated secretory phenotype decrease cancer cell adhesion;2023-12-03
2. Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma;Cell Death & Disease;2023-06-28
3. Trace quantification of GL-V9 and its glucuronide metabolites (5-O-glucuronide GL-V9) in Beagle dog plasma by UPLC–MS/MS and its application to a pharmacokinetic study;PLOS ONE;2023-06-07
4. Multiple strategies for the treatment of invasive breast carcinoma: A comprehensive prospective;Drug Discovery Today;2022-02
5. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics;The FEBS Journal;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3